NCT02645461View on ClinicalTrials.gov

Acetylcholine Receptors From Human Muscles as Pharmacological Target for ALS

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

December 31, 2015

Conditions
Amyotrophic Lateral Sclerosis
Interventions
DRUG

endocannabinoid palmitoylethanolamide (PEA)

Endocannabinoid palmitoylethanolamide (PEA) (ultramicronized) 600 mg twice daily

DRUG

Riluzole

Riluzole 50 mg twice daily

All Listed Sponsors
lead

University of Roma La Sapienza

OTHER

NCT02645461 - Acetylcholine Receptors From Human Muscles as Pharmacological Target for ALS | Biotech Hunter | Biotech Hunter